Overexpression of clusterin correlates with tumor progression, metastasis in gastric cancer: A study on tissue microarrays

Neoplasma

Volumn 57, Issue 3, 2010, Pages 191-197

  Bi, J ^a   Guo, A L ^b   Lai, Y R ^a   Li, B ^a   Zhong, J M ^a   Wu, H Q ^a   Xie, Z ^b   He, Y L ^a   Lv, Z L ^c   Lau, S H ^d   Wang, Q ^a   Huang, X H ^a   Zhang, L J ^a   Wen, J M ^a   Guan, X Y ^a,d  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c GUANGXI MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Clusterin; Gastric carcinoma; Tissue microarray

Indexed keywords

CLUSTERIN; KI 67 ANTIGEN; PROTEIN P53; CLU PROTEIN, HUMAN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; STOMACH CARCINOMA; TISSUE MICROARRAY; AGED; CHEMISTRY; CYTOPLASM; DISEASE COURSE; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; STOMACH TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CLUSTERIN; CYTOPLASM; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; STOMACH NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77954655294     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2010_03_191     Document Type: Article

References (33)

1. ALBERTS SR, CERVANTES A, VAN DE, VELDE CJ. Gastric cancer epidemiology, pathology and treatment. Ann Oncol 2003; 14: 31-36.
2. RODER DM. The epidemiology of gastric cancer. Gastric Cancer 2002; 5: 5-11. doi:10.1007/s10120-002-0203-6
3. WU ZY, LI JH, ZHAN WH, HE YL, WAN J. Effect of lymph node micrometastases on prognosis of gastric carcinoma. World J Gastroenterol 2007; 13: 4122-4125.
4. JONES SE, JOMARY C. Clusterin. Int J Biochem Cell Biol 2002; 34: 427-431
5. ROSENBERG ME, SILKENSEN J. Clusterin: physiologic and pathophysiologic considerations. Int J Biochem Cell Biol 1995; 27: 633-645. doi:10.1016/1357-2725(95)00027-M
6. SHANNON B, SEIFERT M, LESKO K, WILLIS J, BOOTHMAN D, et al. Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer. Cell Death Differ 2006; 13: 12-19. doi:10.1038/sj.cdd.4401779
7. STEINBERG J, OYASU R, LANG S, SINTICH S, RADEMAKER A, et al. Intracellular levels of SGP-2 (Clusterin) correlate with tumor grade in prostate cancer. Clin Cancer Res 1997; 3: 1707-1711.
8. MIYAKE H, GLEAVE M, KAMIDONO S, HARA I. Overexpression of clusterin in transitional cell carcinoma of the bladder is related to disease progression and recurrence. Urology 2002; 59: 150-154. doi:10.1016/S0090-4295(01)01484-4
9. MIYAKE H, HARA S, ARAKAWA S, KAMIDONO S, HARA I. Over expression of clusterin is an independent prognostic factor for nonpapillary renal cell carcinoma. J Urol 2002; 167: 703-706. doi:10.1016/S0022-5347(01)69130-4
10. MIYAKE H, GLEAVE ME, ARAKAWA S, KAMIDONO S, HARA I. Introducing the clusterin gene into human renal cell carcinoma cells enhances their metastatic potential. J Urol 2002; 167: 2203-2208. doi:10.1016/S0022-5347(05)65129-4
11. REDONDO M, VILLAR E, TORRES-MUÑOZ J, TELLEZ T, MORELL M, et al. Overexpression of clusterin in human breast carcinoma. Am J Pathol 2000; 157: 393-399.
12. XIE D, LAU SH, SHAM JS, WU QL, FANG Y, et al. Up-regulated expression of cytoplasmic clusterin in human ovarian carcinoma. Cancer 2005; 103: 277-283. doi:10.1002/cncr.20765
13. LAU SH, SHAM JS, XIE D, TZANG CH, TANG D, et al. Clusterin plays an important role in hepatocellular carcinoma metastasis. Oncogene 2006; 25: 1242-1250. doi:10.1038/ sj.onc.1209141
14. HAMILTON SR, AALTONEN LA, editors. World health organization classification of tumours. Lyon: IARC Press, 2000: 37-68.
15. Japanese Gastric Cancer Association.: Japanese classification of gastric carcinoma. 2nd Eng ed. Gastric Cancer 1; 1998: 10-24.
16. SOBIN LH, WITTEKIND C, editors. TNM classification of malignant tumours. 6th ed. New York: Wiley-Liss, 2002.
17. Xie D, SHAM JS, ZENG WF, LIN HL, CHE LH, et al. Heterogeneous expression and association of beta-catenin, p16 and c-myc in multistage colorectal tumorigenesis and progression detected by tissue microarray. Int J Cancer 2003; 107: 896-902. doi:10.1002/ijc.11514
18. REDONDO M, ESTEBAN F, GONZÁLEZ-MOLES MA, DELGADO-RODRíGUEZ M, NEVADO M, et al. Expression of the antiapoptotic proteins clusterin and bcl-2 in laryngeal squamous cell carcinomas. Tumour Biol 2006; 27: 195-200 doi:10.1159/000093055
19. PUCCI S, BONANNO E, PICHIORRI F, ANGELONI C, SPAGNOLI LG, et al. Modulation of different clusterin isoforms in human colon tumorigenesis. Oncogene 2004; 23: 2298-304 doi:10.1038/sj.onc.1207404
20. KURAHASHI T, MURAMAKI M, YAMANAKA K, HARA I, MIYAKE H. Expression of the secreted form of clusterin protein in renal cell carcinoma as a predictor of disease extension. BJU Int 2005; 96: 895-899 doi:10.1111/j.1464-410X.2005.05733.x
21. KEVANS D, FOLEY J, TENNISWOOD M, SHEAHAN K, HYLAND J, et al. High clusterin expression correlates with a poor outcome in stage II colorectal cancers. Cancer Epidemiol Biomarkers Prev 2009; 18: 393-399. doi:10.1158/1055-9965. EPI-08-0302
22. WATARI H, OHTA Y, HASSAN MK, XIONG Y, TANAKA S, et al. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy. Gynecol Oncol 2008; 108: 527-532. doi:10.1016/j.ygyno.2007.11.026
23. KANG YK, HONG SW, LEE H, KIM WH. Overexpression of clusterin in human hepatocellular carcinoma. Hum Pathol 2004; 35: 1340-1346.
24. REDONDO M, VILLAR E, TORRES-MUNOZ J, TELLEZ T, MORELL M, et al. Overexpression of clusterin in human breast carcinoma. Am J Pathol 2000; 157: 393-399.
25. GUTACKER C, KLOCK G, DIEL P, KOCH-BRANDT C. Nerve growth factor and epidermal growth factor stimulate clusterin gene expression in PC12 cells. Biochem. J 1999; 339: 759-766 doi:10.1042/0264-6021:3390759
26. WEGROWSKI Y, PERREAU C, MARTINY L, HAYE B, MAQUART FX, et al. Transforming growth factor beta-1 up-regulates clusterin synthesis in thyroid epithelial cells. Exp. Cell Res 1999; 247: 475-483 doi:10.1006/excr.1998.4378
27. JIN G AND HOWE PH. Transforming growth factor beta regulates clusterin gene expression via modulation of transcription factor c-Fos. Eur J Biochem 1999; 263: 534-42 doi:10.1046/j.1432-1327.1999.00533.x
28. SHANNAN B, SEIFERT M, LESKOV K, WILLIS J, BOOTHMAN D et al. Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer. Cell Death Differ 2006; 13: 12-9 doi:10.1038/sj.cdd.4401779
29. TROUGAKOS IP, LOURDA M, ANTONELOU MH, KLETSAS D, GORGOULIS VG, et al. Intracellular clusterin inhibits mitochondrial apoptosis by suppressing p53-activating stress signals and stabilizing the cytosolic Ku70-Bax protein complex. Clin Cancer Res. 2009; 15: 48-59 doi:10.1158/1078-0432. CCR-08-1805
30. ZHANG H, KIM JK, EDWARDS CA, XU Z, TAICHMAN R, et al. Clusterin inhibits apoptosis by interacting with activated Bax. Nat Cell Biol. 2005; 7: 909-915. doi:10.1038/ncb1291
31. CRISWELL T, KLOKOV D, BEMAN M, LAVIK JP, BOOTHMAN DA. Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein. Cancer Biol Ther 2003; 2: 372-380
32. PARK DC, YEO SG, WILSON MR, YERBURY JJ, KWONG J, WELCH WR, et al. Clusterin interacts with Paclitaxel and confer Paclitaxel resistance in ovarian cancer. Neoplasia 2008; 10: 964-972
33. MURAMAKI M, SO A, HAYASHI N, SOWERY R, MIYAKE H, et al. Chemosensitization of gemcitabine-resistant human bladder cancer cell line both in vitro and in vivo using antisense oligonucleotide targeting the anti-apoptotic gene, clusterin. BJU Int 2009; 103: 384-90. doi:10.1111/j.1464-410X.2008.08098.x